SKANDINAVISKA ENSKILDA BANKEN AB (PUBL) – Vertex Pharmaceuticals Incorporated Transaction History
SKANDINAVISKA ENSKILDA BANKEN AB (PUBL) portfolio value:
$101.83M
portfolio value
SKANDINAVISKA ENSKILDA BANKEN AB (PUBL) quarter portfolio value change:
+2.75%
quarter
Vertex Pharmaceuticals Incorporated 13F transactions
| Quarter | Transaction type | Change | Relative change | Absolute change | Change value | Avg. price | Shares |
|---|---|---|---|---|---|---|---|
| Q3 2022 | share | Increase | +38.88% | 98.45K shares | 30.47M | $289.54 | 351.71K |
| Q2 2022 | share | Increase | +9.15% | 21.22K shares | 10.81M | $281.79 | 253.25K |
| Q1 2022 | share | Decrease | -19.41% | -55.89K shares | -3.49M | $260.97 | 232.03K |
| Q4 2021 | share | Decrease | -3.41% | -10.16K shares | 9.98M | $222.45 | 287.92K |
| Q3 2021 | share | Decrease | -2.77% | -8.47K shares | -7.74M | $181.39 | 298.08K |
| Q2 2021 | share | Decrease | -11.19% | -38.64K shares | -12.36M | $201.63 | 306.56K |
| Q1 2021 | share | Increase | +29.61% | 78.85K shares | 11.23M | $214.89 | 345.20K |
| Q4 2020 | share | Decrease | -0.87% | -2.32K shares | -10.16M | $236.34 | 266.35K |
| Q3 2020 | share | Decrease | -3.52% | -9.80K shares | -7.73M | $272.12 | 268.67K |
| Q2 2020 | share | Increase | +60.89% | 105.39K shares | 39.65M | $290.31 | 278.48K |
| Q1 2020 | share | Increase | +50.15% | 57.81K shares | 15.94M | $237.95 | 173.09K |
| Q4 2019 | share | Increase | +3.18% | 3.55K shares | 6.31M | $218.95 | 115.27K |
| Q3 2019 | share | Increase | +13.74% | 13.49K shares | 915K | $169.42 | 111.72K |
| Q2 2019 | share | Decrease | -7.65% | -8.13K shares | -1.55M | $183.38 | 98.22K |
| Q1 2019 | share | Increase | +28.84% | 23.80K shares | 5.88M | $183.95 | 106.36K |
| Q4 2018 | share | Increase | +3.34% | 2.67K shares | -1.71M | $165.71 | 82.55K |
| Q3 2018 | share | Increase | +1.53% | 1.2K shares | 2.02M | $192.74 | 79.88K |
| Q2 2018 | share | Increase | +15.37% | 10.48K shares | 2.25M | $169.96 | 78.68K |
| Q1 2018 | share | Decrease | -13.16% | -10.33K shares | -654K | $162.98 | 68.2K |
| Q4 2017 | share | Decrease | -16.57% | -15.6K shares | -2.54M | $149.86 | 78.53K |
| Q3 2017 | share | Decrease | -12.30% | -13.2K shares | 480K | $152.04 | 94.13K |
| Q2 2017 | share | Decrease | -6.77% | -7.8K shares | 1.24M | $128.87 | 107.33K |
| Q1 2017 | share | Decrease | -6.03% | -7.39K shares | 3.56M | $109.35 | 115.13K |
| Q4 2016 | share | Decrease | -15.99% | -23.32K shares | -3.69M | $73.67 | 122.52K |
| Q3 2016 | share | Increase | +1.74% | 2.5K shares | 388K | $87.21 | 145.84K |
| Q2 2016 | share | Decrease | -6.03% | -9.2K shares | 205K | $86.02 | 143.34K |
| Q1 2016 | share | Decrease | -2.24% | -3.5K shares | -7.50M | $79.49 | 152.54K |